Comprehensive Explorations of CCL28 in Lung Adenocarcinoma Immunotherapy and Experimental Validation
DOI: https://doi.org/10.2147/JIR.S399193
IF: 4.5
2023-03-28
Journal of Inflammation Research
Abstract:Xiangyu Su, 1, 2 Guoqing Wang, 3 Shiya Zheng, 2 Chang Ge, 4 Fei Kong, 4 Cailian Wang 1, 2 1 School of Medicine, Southeast University, Nanjing, 210009, People's Republic of China; 2 Department of Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, People's Republic of China; 3 Department of Pathology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, People's Republic of China; 4 Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, People's Republic of China Correspondence: Cailian Wang, Email Background: Chemokines have been reported to play an important role in cancer immunotherapy. This study aimed to explore the chemokines involved in lung cancer immunotherapy. Methods: All the public data were downloaded from The Cancer Genome Atlas Program database. Quantitative real time-PCR was used to detect the mRNA level of specific molecules and Western blot was used for the protein level. Other experiments used include luciferase reporter experiments, flow cytometric analysis, Chromatin immunoprecipitation assay, ELISA and co-cultured system. Results: We found that the CCL7, CCL11, CCL14, CCL24, CCL25, CCL26, CCL28 had a higher level, while the CCL17, CCL23 had a lower level in immunotherapy non-responders. Also, we found that immunotherapy non-responders had a higher level of CD56dim NK cells, NK cells, Th1 cells, Th2 cells and Treg, yet a lower level of iDC and Th17 cells. Biological enrichment analysis indicated that in the patients with high Treg infiltration, the pathways of pancreas beta cells, KRAS signaling, coagulation, WNT BETA catenin signaling, bile acid metabolism, interferon alpha response, hedgehog signaling, PI3K/AKT/mTOR signaling, apical surface, myogenesis were significantly enriched in. CCL7, CCL11, CCL26 and CCL28 were selected for further analysis. Compared with the patients with high CCL7, CCL11, CCL26 and CCL28 expression, the patients with low CCL7, CCL11, CCL26 and CCL28 expression had a better performance of immunotherapy response and this effect might partly be due to Treg cells. Furthermore, biological exploration and clinical correlation of CCL7, CCL11, CCL26 and CCL28 were conducted, Finally, CCL28 was selected for validation. Experiments showed that under the hypoxia condition, HIF-1α was upregulated, which can directly bind to the promoter region of CCL28 and lead to its higher level. Also, CCL28 secreted by lung cancer cells could induce Tregs infiltration. Conclusion: Our study provides a novel insight focused on the chemokines in lung cancer immunotherapy. Also, CCL28 was identified as an underlying biomarker for lung cancer immunotherapy. Keywords: chemokines, lung adenocarcinoma, immunotherapy, Tregs, HIF-1α Globally, lung cancer is considered to be one of the major health concerns, responsible for almost 2.1 million new cases annually. 1 Lung cancer is generally a multifactorial disease that is influenced by many factors, like race, smoking, genetic susceptibility, and so on. 1 Among all subtypes, lung adenocarcinoma is a major one and accounts for approximately 40% of lung cancer. 2 Generally, surgery can provide satisfactory survival benefits to patients with early disease and is still the standard option. 3 Nevertheless, advanced lung cancer is often accompanied by local or distant metastases, making treatment more difficult. 3 Typically, chemotherapy and targeted therapy are used to treat advanced lung cancer, yet toxic side effect is still intractable. Additionally, the sensitivity rate of chemotherapy was only 30%. 4 Immunotherapy is an emerging therapy for lung cancer and has achieved promising results, especially in lung cancer. In the same way, there are still some people who are insensitive to immunotherapy. Gradually, researchers began to notice those indicators that indicated immunotherapy effectiveness. For instance, Zhang et al noticed the signature of CD8+ T cells related genes could indicate the immunotherapy response of lung cancer. 5 Zhou et al found that low-dose carboplatin synergizes with PD-1 inhibitors in lung cancer through the STING signaling pathway. 6 Consequently, it is important and meaningful to explore the underlying factors affecting immunotherapy sensibility. Chemokines are small cytokines or signal proteins secreted by cells, which can induce directional chemotaxis of nearby reactive cells. 7 Also, chemokines can coordinate the migration and localization of immune cells in tissues and therefore exert an impor -Abstract Truncated-
immunology